Orthofix
Orthofix Medical Inc., commonly referred to as Orthofix, is a prominent player in the global medical device industry, headquartered in the United States. Founded in 1980, the company has established itself as a leader in innovative solutions for spinal and orthopaedic conditions, with a strong operational presence across North America, Europe, and Latin America. Orthofix is renowned for its advanced technologies, including its unique bone growth stimulation devices and innovative spinal implants. These products are designed to enhance patient outcomes and streamline surgical procedures, setting Orthofix apart in a competitive market. The company has achieved significant milestones, including numerous regulatory approvals and a robust portfolio of patents, solidifying its position as a trusted provider in the orthopaedic and spine sectors.
DitchCarbon Score
How does Orthofix's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Orthofix's score of 32 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Orthofix's reported carbon emissions
In 2023, Orthofix reported total carbon emissions of approximately 3,363,000 kg CO2e, comprising 669,000 kg CO2e from Scope 1 and 2,694,000 kg CO2e from Scope 2 (market-based). This marks a significant increase from their 2022 emissions, where they recorded about 871,000 kg CO2e globally, with 259,000 kg CO2e from Scope 1 and 2,118,000 kg CO2e from Scope 2 (market-based). In the US specifically, Orthofix's 2022 emissions included 130,000 kg CO2e from Scope 1, 1,447,000 kg CO2e from Scope 2 (market-based), and 60,000 kg CO2e from Scope 3. The company has not disclosed any Scope 3 emissions data for 2023. Despite the increase in emissions, Orthofix has not set specific reduction targets or initiatives, as indicated by the absence of SBTi reduction targets or documented climate pledges. The emissions data is not cascaded from any parent company, and all figures are reported directly from Orthofix Medical Inc. Overall, while Orthofix has made strides in transparency regarding their emissions, their lack of defined reduction commitments highlights an area for potential improvement in their climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 871,000 | 000,000 |
| Scope 2 | 2,118,000 | 0,000,000 |
| Scope 3 | 68,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Orthofix is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
